X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

4 things to know about the QuintilesIMS drivers of medicine spending in the U.S. report

By Holly Campbell  |    September 28, 2017
In case you missed it, a new analysis from QuintilesIMS, which draws on the Medicines Use and Spending in the U.S. — A Review of 2016 and Outlook to 2021 report and the Outlook for Global Medicines...   Read More

Profiles in courage: Latinos in the fight against Alzheimer’s

By Guest Contributor  |    September 28, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Biopharma leads sustained economic growth driven by IP-intensive industries

By Tim McClung  |    September 26, 2017
While the biopharmaceutical industry is the global leader in generating innovative medicines and technologies, lesser known is the industry’s central role in sustaining economic growth. A recent...   Read More

Johnson & Johnson, Pfizer, Walgreens and other CEOs discuss value in the future of health care

By Holly Campbell  |    September 21, 2017
As part of The Value Collaborative, an initiative of America’s biopharmaceutical companies, we recently hosted an event with Bloomberg about unlocking and supporting value in the future of health...   Read More

The journey to better health care requires a holistic view

By Guest Contributor  |    September 18, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

What they are saying: Study on cancer R&D costs is not an accurate representation of marketplace

By Holly Campbell  |    September 12, 2017
This post has been updated as of 10/2/2017 A recent study published in JAMA Internal Medicine provides flawed and inaccurate estimates of the significant research and development (R&D) investments...   Read More

Medicare Monday: Medicare Part D by the numbers

By Nicole Longo  |    September 11, 2017
Getting back into the swing of things as Fall approaches? Here’s some light Medicare reading! And if you need a refresher, you can go back to our ABC (and Ds) of Medicare post:   Read More

Working to harness the power of the body’s own immune system

By Guest Contributor  |    September 7, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

How biopharmaceutical collaboration is driving a new era of medicine

By Andrew Powaleny  |    September 7, 2017
Biopharmaceutical innovation, coupled with technological advancements, has brought a new era of medicine transforming how we research and develop new medicines to benefit patients.   Read More

Protect your health: Important disaster preparedness tips for Harvey and Irma

By Guest Contributor  |    September 6, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates